Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.

Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.

Item
http://www.wikidata.org/entity/Q35050195
Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancerThe Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link.Targeted therapy for soft tissue sarcomas in adolescents and young adults.Immune Therapy for Sarcomas.Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer.A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer.DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer.
P2860

Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.

Item
http://www.wikidata.org/entity/Q35050195
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Anticancer activity of the typ ...... ceptor 5 agonist, conatumumab.
@ast
Anticancer activity of the typ ...... ceptor 5 agonist, conatumumab.
@en
type
label
Anticancer activity of the typ ...... ceptor 5 agonist, conatumumab.
@ast
Anticancer activity of the typ ...... ceptor 5 agonist, conatumumab.
@en
prefLabel
Anticancer activity of the typ ...... ceptor 5 agonist, conatumumab.
@ast
Anticancer activity of the typ ...... ceptor 5 agonist, conatumumab.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Anticancer activity of the typ ...... ceptor 5 agonist, conatumumab.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932